Literature DB >> 15790792

FDA labors over NSAID decisions: panel suggests COX-2 inhibitors stay available.

Donna Young.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15790792     DOI： 10.1093/ajhp/62.7.668

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN： 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  5 in total

Review 1.  An evidence-based update on nonsteroidal anti-inflammatory drugs.

Authors:  C K S Ong; P Lirk; C H Tan; R A Seymour
Journal:  Clin Med Res       Date:  2007-03

2.  Nephrotoxicity with cyclooxygenase 2 inhibitor use in children.

Authors:  Jeffery T Fletcher; Nicole Graf; Anthony Scarman; Hamda Saleh; Stephen I Alexander
Journal:  Pediatr Nephrol       Date:  2006-09-06       Impact factor: 3.714

3.  Lack of Pharmacokinetic Interaction between Esomeprazole and the Nonsteroidal Anti-Inflammatory Drugs Naproxen and Rofecoxib in Healthy Subjects.

Authors:  M Hassan-Alin; J Naesdal; C Nilsson-Pieschl; G Långström; T Andersson
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

4.  Amorphisation of Free Acid Ibuprofen and Other Profens in Mixtures with Nanocellulose: Dry Powder Formulation Strategy for Enhanced Solubility.

Authors:  Athanasios Mantas; Valentine Labbe; Irena Loryan; Albert Mihranyan
Journal:  Pharmaceutics       Date:  2019-02-06       Impact factor: 6.321

5.  Ibuprofen can induce syndrome of inappropriate diuresis in healthy young patients.

Authors:  Céline Roche; Céline Ragot; Jean-Luc Moalic; Fabrice Simon; Manuela Oliver
Journal:  Case Rep Med       Date:  2013-06-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.